Research Article of Open Journal of Gastroenterology and Hepatology
Oral health status of patients with decompensated liver cirrhosis in two hospitals of Yaoundé Cameroon: A comparative study
Mathurin Pierre Kowo1,2, Alex Franklin Diffo1, Marie Elvire Nokam Abena1, Larry Tangie Ngek1, Antonin Wilson Ndjitoyap Ndam1,3, Rose-Claire Bitha1, Firmin Ankouane Andoulo1,4
1Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Cameroon; 2University Hospital Centre, Yaoundé, Cameroon; 3Yaoundé General Hospital, Yaoundé, Cameroon; 4Yaoundé Central Hospital, Yaoundé, Cameroon
Background: Liver cirrhosis is an ultimate complication of all chronic liver diseases. The oral cavity especially the periodontium is affected by malnutrition, coagulation disorders, immunodeficiency which are some of the main features present in patients with liver cirrhosis. The aim of this study was to determine the prevalence and determinants of oral pathologies in patients with decompensated liver cirrhosis in two hospitals of Yaoundé Cameroon.
Patients and Methods: This was a cross-sectional and analytical study comparing the oral health status of decompensated liver cirrhotic patients in Yaoundé with sex and age (±3 years) matched healthy controls from the same area. We enrolled patients with liver cirrhosis (Child Pugh score greater than or equal to 7) and their corresponding healthy controls. For each participant, socio-demographic data, clinical data on liver cirrhosis and on oral examination were collected. Oral examination evaluated the level of oral hygiene, gingival index (GI), probing depth (PD) and Clinical attachment loss (CAL), determined and identified oral mucosal lesions. The mean Decayed-Missing-Filled-Teeth (DMFT) index and prevalence of dental caries were also determined. The groups were then compared with regards to periodontal oral mucosal and dental variables using chi square test and Mantel – Haenszel odds ratio was used to determine the strength of association between decompensated liver cirrhosis and oral pathologies. The student‘s T-test was used to compare mean values of quantitative variables. A p-value ˂ 0.05 was statistically significant.
Results: We included a total of 80 participants among which 40 liver cirrhotic patients and 40 sex and age (±3 years) matched controls. The mean age was 50.0(±19.0) years for the cases and 52.4(±17.9) years for the healthy controls. Hepatitis B virus (HBV) and Hepatitis C virus (HCV) were the main aetiology of liver cirrhosis representing 42.5% and 30% respectively and Child Pugh class B (65% of cases) was the most represented stage of the disease. A number of past bucco-dental consultations was significantly less frequent in the cases than the controls (09 versus 18, p = 0.03). Over 80% of cases used an inappropriate brushing technique compared to 60% of controls and 55% of cases used toothbrushes and toothpaste compared to 85% controls (p=0.09). A frequency of brushing at least twice daily was 42.5% in cases compared to 55% in controls (p=0.19). Patients with decompensated liver cirrhosis had a significantly greater prevalence of periodontal disease than the controls (95% versus 77.5%, p = 0.013). In addition, they had greater mean PI (1.8(±0.7) versus 1.6(±0.5), p = 0.182), mean GI index (1.9(±0.8) versus 1.3(±0.64), p = 0.004) and periodontal recession (77.5% versus 47.5%). Oral mucosal lesions and salivary lesions were more frequent in cirrhotic patients than in the healthy controls. These lesions include xerostomia (45% versus 17.5%, p ˂0.001), oral candidiasis (7.5% versus 0%, p = 0.120), lichen planus (17.5% versus 2.5%, p = 0.028), petechiae (57.5% versus 5%, p ˂ 0.001), halitosis (50% versus 7.5%, p ˂0.001) and sialadenitis (17.5% versus 0%, p = 0.006). Higher prevalence’s of dental and mean DMFT index were found in cases than in controls. Factors associated with the development of oral pathologies in decompensated cirrhotic patients were oral consultations (p = 0.046), presence of cytolysis (OR = 2.58, p = 0.042) and inadequate brushing technique (p = 0.004).
Conclusion: The prevalence of oral pathologies is higher in patients with decompensated liver cirrhosis than corresponding age-sex matched healthy controls.
Keywords: decompensated liver cirrhosis; oral health status; Yaoundé
How to cite this article:
Mathurin Pierre Kowo, Alex Franklin Diffo, Marie Elvire Nokam Abena, Larry Tangie Ngek, Antonin Wilson Ndjitoyap Ndam, Rose-Claire Bitha, Firmin Ankouane Andoulo.Oral health status of patients with decompensated liver cirrhosis in two hospitals of Yaoundé Cameroon: A comparative study. Open Journal of Gastroenterology and Hepatology, 2021, 4:44. DOI: 10.28933/ojgh-2021-01-0608
1. Petersen PE, Bourgeois D, Ogawa H, Estupinan-Day S, Ndiaye C. The global burden of oral diseases and risks to oral health. Bull World Health Organ. 2005;83(9):661‑96.
2. Kassebaum NJ, Smith AGC, Bernabé E, Fleming TD, Reynolds AE, Vos T et al. Global, Regional, and National Prevalence, Incidence, and Disability-Adjusted Life Years for Oral Conditions for 195 Countries, 1990-2015: A Systematic Analysis for the Global Burden of Diseases, Injuries, and Risk Factors. J Dent Res. 2017;96(4):380‑7
3. Zamora Nava LE, Aguirre Valadez J, Chávez-Tapia NC, Torre A. Acute-on-chronic liver failure: a review. Ther Clin Risk Manag. 2014;10(6):295‑303
4. Jankowska I, Neuhoff-Murawska J, Socha P, Paw\lowska J, Socha J. Clinical aspects of nutrition in children with chronic cholestasis–on the basis of a selected case. Gastroenterol Rev Gastroenterol. 2008;3(3):139–42.
5. Elhassan AT, Peeran SW. The Linking Mechanisms Between Liver and Periodontal Diseases. EC dental science. 2016;4(2)758-66
6. Bilounga Ndongo C, Eteki L, Siedner M, Mbaye R, Chen J, Ntone R, et al. Prevalence and vaccination coverage of Hepatitis B among healthcare workers in Cameroon: A national seroprevalence survey. J Viral Hepat. Wiley Online Library; 2018;25(12):1582–7.
7. Bigna JJ, Amougou MA, Asangbeh SL, Kenne AM, Noumegni SRN, Ngo-Malabo ET, et al. Seroprevalence of hepatitis B virus infection in Cameroon: a systematic review and meta-analysis. BMJ Open. British Medical Journal Publishing Group; 2017;7(6):p12.
8. Di Profio B, Inoue G, Marui VC, de França BN, Romito GA, Ortega KL, et al. Periodontal status of liver transplant candidates and healthy controls. J Periodontol. 2018;89(12):1383‑9.
9. Costa FO, Lages EJP, Lages EMB, Cota LOM. Periodontitis in individuals with liver cirrhosis: A case–control study. J Clin Periodontol. oct 2019;46(10):991‑8.
10. Bisse NAM. Aspects épidémiologiques et cliniques des parodontopathies sur cirrhose du foie au CHUY et HGY. Université de Yaoundé I. Faculté de Médecine et des Sciences Biomédicales ; 2015, p106 [cité 10 juill 2020]. Disponible sur: https://www.hsd fmsb.org/index.php/hsd/thesis/view/220.
11. Lins L, Bittencourt PL, Evangelista MA, Lins R, Codes L, Cavalcanti AR, et al. Oral Health Profile of Cirrhotic Patients Awaiting Liver Transplantation in the Brazilian Northeast. Transplant Proc. mai 2011;43(4):1319‑21. 43.
12. Santos PS da S, Fernandes KS, Gallottini MHC. Assessment and management of oral health in liver transplant candidates. J Appl Oral Sci. Faculdade De Odontologia De Bauru – USP; 2012;20(2):241‑5
13. Mitchell S, Ayesh R, Barrett T, Smith R. Trimethylamine and foetor hepaticus. Scand J Gastroenterol. mai 1999;34(5):524‑8.
14. Bollen CM, Beikler T. Halitosis: the multidisciplinary approach. Int J Oral Sci. 2012;4(2):55‑63
15. Panov VE. Oral Manifestations of Hepatitis C Virus. J IMAB – Annu Proceeding Sci Pap. 1 oct 2013;19(4):377‑9.
16. Carrozzo M, Scally K. Oral manifestations of hepatitis C virus infection. World J 16. GastroenterolWJG. 2014 June 28;20(24):7534-43.
17. Alavian S-M, Mahboobi N, Mahboobi N, Karayiannis P. Oral conditions associated with 17. hepatitis C virus infection. Saudi J Gastroenterol Off J Saudi Gastroenterol Assoc. 2013;19(6):245
18. Ali A, Zein NN. Hepatitis C infection: a systemic disease with extrahepatic manifestations. Cleve Clin J Med. Cleveland Clinic Foundation; 2005;72(11):1005.
19. Agbo-Godeau S, Guedj A. Mycoses buccales. EMC-Stomatol. Elsevier; 2005;1(1):30–41.
20. Baker PJ, Dixon M, Evans RT, Dufour L, Johnson E, Roopenian DC. CD4+ T cells and the proinflammatory cytokines gamma interferon and interleukin-6 contribute to alveolar bone loss in mice. Infect Immun. Am Soc Microbiol; 1999;67(6):2804–9.